Introduction
Nasogastric tubes (NGT) are widely used in health care but carry with them a recognized morbidity and mortality risk. Although individual risk is low, given the extent of NGT usage an unacceptable amount of patient harm is resultant from these tubes on an annual basis. This finding is especially pertinent given that with correct placement confirmation, the entirety of this burden on patient harm may be eliminated (Krenitsky 2011) . Several placement confirmation methods are available but of these only pH testing and chest x-rays are advocated in UK clinical guidelines (National Patient Safety Agency (NPSA) 2011a). pH testing may be performed relatively cheaply at the bedside but at a lower accuracy than the more expensive chest x-ray method (Ellet 2004) . There is currently international disparity in the cost and effectiveness trade-off between these two tests, however no formal economic evaluation exists in the evidence base. This study therefore attempts to address this knowledge gap.
Background
The insertion of a NGT is the passage of a tube, appropriate for its intended purpose, via the nostril into the stomach (National Institute for Clinical Excellence 2006). NGTs are used in clinical practice for a wide variety of reasons and thus NGT placement is an extremely common clinical intervention, with an estimated 170,000 feeding tubes being used annually in the UK alone (Eveleigh et al. 2011) . Although the majority of these tubes are inserted and used without incident, there is a recognized risk that the tube can be misplaced into the lungs, or move out of the stomach (Burns et al. 2001) .
Confirmation of NGT placement is required immediately following insertion and subsequently prior to each use (e.g. administration of enteral feed or medication). In addition, the tube should be checked following episodes of vomiting, retching or coughing spasms, after oropharyngeal suction has been required or where there is a suggestion of tube displacement. Any new or unexplained respiratory symptoms or a drop in oxygen saturation readings is a further indication for seeking repeated confirmation of NGT placement (Durai et al. 2009 ).
pH testing of gastric aspirate obtained via the NGT is recommended as a first line test method for establishing correct position. A pH reading between 1-5Á5 is considered a reliable method for excluding placement in the pulmonary tree; however, is not a definitive confirmation of gastric placement. When aspirate is not able to obtained, or first line pH testing is inconclusive, national guidelines recommend placement confirmation with a chest x-ray (NPSA 2011b) . These tests may only be foregone in patients where the placement of the NGT is completed under direct visualization of a surgeon or anaesthetist (e.g. patients undergoing gastric surgery or endoscopy procedures) (NPSA 2011a) .
Although the majority of these tubes are inserted and used without incident, there is a recognized risk that the tube can be misplaced into the lungs, or move out of the stomach. Published reports of incidents have included oesophageal, peritoneal and intestinal placement and NGTs placed in the brain (Burns et al. 2001) . In addition, severe pulmonary complications, indeed mortality, have been reported as a direct result of NGT placement in the respiratory tract (Miller 2011) . Between September 2005-March 2010, 21 deaths and 79 cases of harm relating to feeding Why is this research or review needed?
• Nasogastric tubes are frequently used in clinical practice but despite the availability of robust checking procedures, the procedure is still recognized as a cause of avoidable mortality and morbidity.
• Patient safety alerts have called for the review of all clinical guidelines in relation to nasogastric tube care.
• There is international disparity in the cost and effectiveness trade-off between the two most commonly used methods of nasogastric tube confirmation (pH testing and xray).
What are the key findings?
• Even if no complications occur, nasogastric tube insertion still impacts the patient's perceived health state.
• Compared with no checking procedure, chest x-ray is a more effective but more expensive approach than pH testing of aspirate for nasogastric tube placement confirmation.
• Using chest x-ray as the first line checking procedure for nasogastric tube placement confirmation without testing pH of aspirate significantly increases costs.
How should the findings be used to influence policy/ practice/research/education? through misplaced NGTs were reported (NPSA 2011a). Due to these serious consequences, NGT misplacement was included as one of the eight 'Never Events' identified by the NSPA (2010a).
Despite this, the second highest reported Never Event in the period between 2009-2010 was NGT misplacement, with 41 reports of statistically significant patient safety incidents (NPSA 2010b). In addition, several of these incidents occurred despite the recommended first and second line tests being undertaken, with the NPSA directly attributing 45 incidents between 2005-2011 to cases of misinterpretation (NPSA 2011b) .
With recent national safety alerts prompting the revision of all clinical guidelines in relation to NGT care, a formal evaluation which assesses the outcomes of patients in relation to the two currently recommended methods is timely and indicated. Clinical guidelines from the US outline that blindly placed NGT placement should always be verified radiologically (Metheny 2009 ). There is, therefore, international disparity in the decision-making trade-off between the more efficacious but costly chest x-ray alternative against the cheaper but potentially less specific pH testing of aspirate. The existence of this disparity demonstrates that robust evaluations of the current methods for NGT placement confirmation in terms of both patient outcomes and cost are not yet available. An economic evaluation of the currently recommended confirmation algorithm will inform future guideline development and has clear policy implications for patient safety on both a national and international platform.
The study Aims
The aim of this research was to evaluate the effectiveness of pH paper testing of aspirate and chest x-ray as outlined in the currently recommended NPSA algorithm (NPSA 2011c) for determining NGT placement in terms of cost and patient outcome for adult patients.
Design
This study was a cost utility analysis comparing the costs and consequences of using chest x-ray vs. pH testing of aspirate as first line procedures for checking NGT placement. Consequences were measured in terms of quality of life using quality adjusted life years (QALYs).
The study adopted a third party payer perspective (NHS) based in Scotland. The time horizon was set at 6 weeks, in line with the National Institute for Clinical Excellence (2006) definition of short-term NGT placement and incorporating the average length of inpatient hospital stay (4Á8 days) in the study setting (ISD Scotland 2012a). Given the short time horizon, a 0% discount rate was applied (Husereau et al. 2013) . The study was completed in June 2013.
Sample/participants
To increase the homogeneity of the patient group and increase the validity of the comparison, the patient population inclusion criteria were:
• adult patients; defined through admission to an adult care area A total of three studies were included in the synthesis for chest x-ray effectiveness (Ghahremani & Gould 1986 , Sorokin and Gootlieb 2006 , de Aguilar-Nascimento & Kudsk 2007 . Details of the complications were assessed individually and grouped according to the criteria where Low Harm was indicated by no additional treatment required and no delay in discharge, Moderate Harm requiring some additional treatment in the same care area and a slight delay in discharge and Severe Harm as requiring additional extensive treatment with care in a higher dependent area (such as HDU or ITU) and a statistically significant delay in discharge home. A summary of the data is provided in Table 2 .
No single studies were available which evaluated the performance of pH testing in relation to specific complication rates and patient outcomes, therefore, the effectiveness data were calculated using a two stage approach. Initially to calculate effectiveness, a total of three studies were identified (Metheny et al. 1999 , 2000 , Kearns & Donna 2001 and data were extracted and used to construct 2 9 2 tables of true positive, false positive, true negative and false negative cases for each. All data were classified as binary (either gastric placement, or not) therefore no threshold for test positivity was required (Deeks et al. 2010) . Sensitivity, specificity and a 95% CI for each study were then calculated using RevMan 5Á2 software (The Nordic Cochrane Centre, The Cochrane Collaboration 2012). Finally, these data were combined in meta-analysis using Meta-DiSc 1Á4 software (Zamora et al. 2006) to calculate the pooled sensitivity of pH testing across the three studies (sensitivity 0Á823, CI 0Á803-0Á843).
A further three studies (Metheny et al. 1989 , Welch et al. 1994 , Neumann et al. 1995 were added to two from the meta-analysis to calculate the probability of obtaining 6 included in synthesis:
1. x-ray: 3 2. pH testing: 3 3. Ability to obtain aspirate: 3 Figure 1 Flow diagram of search results.
aspirate from the NGT ( Table 3 ). The study by Metheny et al. (2000) was excluded from this calculation as data were reported on aspirate pH ability to detect correct NGT placement, not the ability to obtain aspirate for testing. All possible outcomes were assumed equally likely and therefore probability was calculated by dividing the number of instances of aspiration success by the total number of attempts. Finally, probability weights for complication incidence were calculated from published NRLS patient safety incident report data (NPSA 2008) with the levels of complication calculated from narratives of these incidents provided in Hannah et al.'s (2010) NHS report into improving NGT safety. Overall probability of complications was calculated as per aspiration success. The number of complications was used as the denominator when calculating probability weights for each level of harm.
Measurement and valuation of preference based outcomes
Utility values for health states were sought where, following NGT placement, confirmation no complications, mild, moderate and severe complications were encountered. As none were available in the existing literature, these were gathered directly from patients. A sample of 31 patients admitted to an acute surgical unit were provided with four vignettes of the health states under consideration (see Figure  2 ) and asked to value each one using the EQ-5D instrument (The EuroQol Group 1990). The vignettes described four scenarios involving NGT insertion and checking, ranging from a simple insertion and check with no complications to an NGT insertion that resulted in statistically significant, severe complications which required intervention and an extended hospital stay. The vignettes were based on actual NGT placement related adverse events reported by Hannah et al. (2010) and were supported by a patient information sheet including details of the clinical indication of a NGT and the checking procedures. Participants were asked to imagine that they were the patient described in the scenario and rate the impact of the hypothetical events on their health and well-being using the scoring tools in the EQ-5D. Seven patients declined participation; one agreed but did not complete the documentation resulting in a final sample of 23. The EQ-5D was self-administered and completed anonymously.
The ratings for each health state were converted using the EQ-5D-5L Value Sets Crosswalk Index Value Calculator and also calculated using the visual analogue scale (VAS) scores. The recommendations of Dolan (2000) were used to aggregate the valuations for each health state, with the skewed distribution (for all health state valuations expect Moderate Complications) guiding the choice of median (with 25th and 75th percentiles) over mean for QALY calculations.
Estimating resources and costs Cost data used current NHS prices in relation to consumables and investigation costs. Staff costs in terms of time were calculated using the mid-point of the NHS pay scale for all relevant staff members required. Oncosts were considered in accordance with the perspective of the study. Costs for repeated chest x-ray placement confirmation when Table 4 .
Ethical considerations
Research Ethics Committee approval was sought from the local NHS ethics committee for the valuation of preference based outcomes but was deemed not necessary due to the nature of the information sought. The project was considered a service evaluation.
Data analysis
All data were analysed using a decision tree model built using TreeAge Pro Healthcare software (TreeAge Software Inc 2013). The model structure and all study parameters entered can be seen in Figure 3 .
Validity and reliability/rigour
The model required several assumptions. As the time horizon was set at 0Á125 years, no discounting was applied. The baseline patient characteristics were adult surgical patients with no artificial airway in situ and not nursed in a low to medium dependency area. The model assumes one NGT per patient over the time horizon of the study. Efficacy of each method (pH testing and chest x-ray) was expressed in terms of probability of complication and level of complication, with the ability to confirm NGT position per x-ray set at 94% (failure rate of 6%) and ability to obtain aspirate for pH testing set at 87% (failure rate of 13%). If the NGT position was not confirmed in two x-rays, the model assumes that the checking procedure would be abandoned. In terms of cost inputs, radiology staff costs were incorporated into the costs of the x-ray, with interpretation costs separate. Low complications assumed no additional treatment was required, moderate complications required additional ward bed days, chest drain insertion and additional care and severe complications required intensive care. Only the costs of the confirmation method were used for the Death health state outcome.
In terms of utility inputs, the model assumed that these would be the same for each health state outcome, regardless of checking procedure. Where the checking procedure is abandoned (i.e. when no method can confirm placement), no utility is gained. Base case assumptions and parameter uncertainties were explored using one way deterministic sensitivity analysis.
Results

Utility of NGT placement and subsequent complications
The EQ-5D instrument was completed anonymously; therefore, no sample characteristics are available to report. Given the nature of the care area (an adult surgical unit), it can be assumed that all participants were over 16 years of age. Despite experiencing no complications, the insertion of an NGT still resulted in a slight dip in health, as rated by the 23 participants. As expected, the utility values decrease as the severity of complications with NGT placement increase. The mean and median values remain similar using the VAS utility values, contrasted with those obtained from the index ratings. Overall, utility ratings for all health states were higher using the VAS part of the EQ-5D instrument with the most noticeable difference in Severe Complications health state. See Table 5 for a summary.
Cost utility
The base case is compared with no checking procedure and thus zero utility attributed to a non-functioning NGT. Each checking procedure was considered in turn as the base case (pH testing and chest x-ray). Compared with no checking procedure, chest x-ray delivers a higher QALY gain than pH testing when compared no checking procedure (0Á12 QALYs vs. 0Á11 QALYs) but also at higher cost (x-ray costs £1322Á00 per QALY gained, pH testing £392Á73 per QALY gained). If the base case is altered to pH testing, the cost effectiveness in terms incremental cost effectiveness ratio (ICER) for chest x-ray rises significantly. Compared with no checking procedure, the cost per QALY of checking NGT position by x-ray alone without attempting aspiration for pH testing first is £11,544.
Sensitivity analysis
Aspiration success has considerable impact on the ICER of pH testing, with lower success rates resulting in a 22% increase from the base case. pH confirmation success rate had only marginal impact, which appears logical given the narrow confidence interval range. Upper and lower bound chest x-ray complication rates also resulted in statistically significant alterations to the base case ICER. Again, this appears logical given that chest x-ray is the 'backup' confirmation method when aspiration or pH testing confirmation Upper and lower bound chest x-ray complication rates also greatly impact the chest x-ray ICER. Lower complication rates result in an ICER decrease of 19Á5%. Again, the higher VAS health state valuations impacted on the ICER (around a 10% increase) and the impact of the increased cost of Death health state resulted in a 33% increase in ICER, slightly more than the increase noted for pH testing in the same analysis. A summary of the base case cost utility results and sensitivity analyses can be found in Table 6 .
Discussion
NGT placement is an extremely common clinical intervention with the majority of tubes passed without complication. However there is a recognized risk that during the procedure, because the practitioner is blinded to the final placement, the NGT may be misplaced into the lungs. Placement confirmation methods are therefore required and currently, pH testing of aspirate and chest x-ray is recommended in UK national guidelines (NPSA 2011c) although international disparity exists on best practice recommendations (Metheny 2009 ). In addition, no previous economic evaluation has been completed which compares the two currently recommended confirmation methods.
Clinical outcome was measured through QALY gains, adjusted to the 0Á125 year timeline of the study. In terms of effectiveness, both pH testing and chest x-ray produce QALY gains when compared with no checking procedure. Chest x-ray produces a slightly higher QALY (0Á01) than pH testing. In terms of cost, compared with a base case of no confirmation procedure, the incremental cost of pH testing is £43Á20 which is significantly lower than the £158Á64 of chest x-ray. This results in an ICER for pH testing of £392Á73 per QALY, over a third lower than chest x-ray (ICER £1322 per QALY). When compared with a base case of pH testing, foregoing any attempt to aspirate the NGT in the first instance, the costs of chest x-ray as first line confirmation results in a significantly higher ICER of £11,544 per QALY gained. This appears logical given that chest xray confirmation offers only a 0Á01 QALY gain over pH testing as a first line attempt. As no previous work has evaluated the cost effectiveness of the NGT checking procedure, a comparison to other published work as recommended by Philips et al. (2004) is not possible. The current UK algorithm advocated by the NPSA (2011c) therefore appears to offer the most cost effective approach to NGT confirmation in terms of QALYs gained. However, the results of the sensitivity analysis indicate that these findings may be significantly altered by NGT aspiration success and the rates of chest x-ray interpretation errors. The ability of obtaining aspirate from a NGT for pH testing may be influenced by several factors. Smaller bore feeding tubes are more liable to collapse when negative pressure is applied (Crocker et al. 1981) , with Silk et al. (1987) also finding that changing the material of the tube itself (from polyvinyl chloride to polyurethane) leads to statistically significant (P < 0Á001) increases in aspiration attempt success. It should be noted that the probability of obtaining aspirate for this study was calculated at 0Á87 from five studies identified as part of the systematic literature search, with two studies from Metheny et al. (1989 Metheny et al. ( , 1999 . Norma Metheny is extensively published in the field of NGT care and is considered an expert in the field. Indeed, she has published specific guidelines on how to maximize aspiration success of NGTs (Metheny et al. 1993) . The two studies from Metheny et al. (1989 Metheny et al. ( , 1999 contributed to over half of the data (57%) for the estimation of aspiration success for this current work and, therefore, may have increased the estimate to above what may be achieved by non-experts in the field. Sensitivity analysis was used using a range of aspiration success rates to explore this impact on the study ICER estimate. Similarly, in a systematic review by Sparks et al. (2011) clinician experience in x-ray interpretation was found to impact on the rate of complications encountered.
A patient who is currently in hospital for surgery who is otherwise fit and well. They have a nasogastric tube inserted and the position is checked according to the current clinical guidelines. No complications arise and no treatment is required as a result of the nasogastric tube A patient who is currently in hospital for surgery who is otherwise fit and well. They have a nasogastric tube inserted and the position is checked according to the current clinical guidelines. Some complications arise as a result of the nasogastric tube insertion. The patient experiences some harm from this but it is considered a low amount. No additional treatment is required. They are fully mobile and in some minor pain from the nasogastric tube. Discharge home will not be delayed.
A patient who is currently in hospital for surgery who is otherwise fit and well. They have a nasogastric tube inserted and the position is checked according to the current clinical guidelines. Some major complications arise as a result of the nasogastric tube insertion. The patient harm from this and it is considered a moderate amount. Additional treatment is required but they experiences are cared for in the same ward. Their condition deteriorates but is treated successfully. Their mobility is limited as a result of these events and they require help to wash, dress and go to the toilet. Discharge home will be delayed, but not significantly.
A patient who is currently in hospital for surgery who is otherwise fit and well. They have a nasogastric tube inserted and the position is checked according to the current clinical guidelines. Some significant complications arise as a result of the nasogastric tube insertion. The patient experiences harm from this and it is considered a severe amount. Additional treatment is required and they require care in the Intensive Care Unit. Their condition deteriorates and they require surgery as a result. Ultimately they are treated successfully. Their mobility is limited as a result of these events and they require help for all activities. Discharge home will be significantly delayed. Estimation of complication rates for chest x-ray in this study was generated using observational data and therefore should better reflect the heterogeneity of clinicians' interpretation abilities in actual clinical practice (Black 1999) . Sensitivity analyses facilitated a further exploration of the impact of this potential variable on the study ICER estimates. However, it should be noted that strategies to improve chest x-ray interpretation for NGT placement confirmation (and thus lower complication rates) such as the training tool described by Eveleigh et al. (2011) also carry a cost which may offset any savings gained. If such strategies are used then the additional cost of training needs to be considered in any future economic evaluation, particularly if the third party payer perspective is maintained. Alterations in the base case resulted in statistically significant increases in the cost per QALY gained. This finding has particular relevance to international clinical policy comparisons. The model for the current work mirrors the current UK NGT placement confirmation algorithm advocated by the NPSA (2011c), whereby first line checking should begin with attempt at aspiration for pH testing before proceeding to chest x-ray. However, new clinical guidelines endorsed by professional bodies in the USA, Canada and Europe state that 'every patient should undergo radiography to confirm proper position of an NG or OG tube before feeding is initiated' (Itkin et al. 2011, p746 ). The study model demonstrates that foregoing pH testing as a first line method of NGT placement confirmation results in an increase in cost per QALY gained of £10,222. Even accounting for the potential lack of precision of pH testing and subsequent possible complications, it appears that using this cheap (incremental cost of £4Á40) bedside test as a first line method offers a more cost effective approach to NGT placement confirmation in terms of cost per QALY gained. This is particularly significant when considered in the light of the frequency of the NGT placement confirmation procedure, estimated by Krenitsky (2011) to be 1Á2 million annually in the USA alone.
This study setting was the Scottish NHS and a third party payer perspective was adopted. Since the passing of the Scotland Act (Great Britain Parliament 1998) the powers to run the NHS in Scotland have been devolved to the Scottish Government. As a result, NHS Scotland displays some systemic differences to that of NHS England and Wales. One of these differences is the Never Event framework (Department of Health 2011). This list of 25 preventable events carries a financial penalty for the provider if they occur, with a £10,000 payment levied on top of the recovery of costs of care and procedures to date should a death occur (NPSA 2010a) . To enable extrapolation of the study results to the wider UK perspective, the cost of a never event due to misplaced NGT (£10,000 plus costs of Severe Complications health state) was added to the model. The resultant incremental costs are an increase of £19Á74 for pH testing and £82Á74 for chest x-ray compared with the Scottish NHS base case for the same QALY gains. Consequently, the ICERs are also increased by 46% and 52% for pH testing and chest xray respectively. pH testing therefore still remains the most cost effective option in terms of incremental cost and QALYs gained when compared with no checking, therefore, the national NPSA algorithm (2011c) is correctly used throughout the UK. However, it should be noted that the cost of obtaining QALY gains through NGT placement confirmation in the NHS England and Wales context is considerably higher than in NHS Scotland. This result is driven purely by the policy differences between the two bodies.
Limitations
The generalizability of the study results are limited to the base case patient demographic and setting (i.e. adult surgical patients with no airway in situ receiving general ward based care). Several factors are known to increase the incidence of complications with NGT placement such as age, with paediatric populations at higher risk than adults (Ellet et al. 1998 ). In addition, bronchial placement of NGTs is more prevalent among patients with reduced conscious levels or those receiving mechanical ventilation (Stroud et al. 2003) . As such, the findings from this study would represent an underestimate if applied to these high risk groups. However, as heterogeneity is known to impact on both costs and effectiveness (Coyle et al. 2003) , it would not have been appropriate to include both high and normal risk groups here for the comparison under study. The economic model structure accurately mirrors the current NPSA algorithm (NPSA 2011c) and therefore could be easily used and updated with data for various subgroups to gain ICER estimates for the NGT placement confirmation procedure across a variety of risk profiles.
There was an acknowledged lack of data pertaining to the specific study setting (Scotland) and as a result data from other areas of the UK were used. Although this may influence the study results, where possible NHS based information was used to minimize the impact of this potential bias. In addition, a reliance on published data for a variety of model inputs (e.g. complication rates and outcomes) may impact the study results through publication bias (Easterbrook et al. 1991 ). An attempt to minimize this impact was undertaken through a systematic approach to literature searching and extending the search to include grey literature. In addition, the UK NHS perspective may limit the transferability of the study findings to international settings. However, given the results of the sensitivity analysis it would be anticipated that similar results would be generated in other healthcare systems whereby pH testing was associated with lower costs when compared with the chest x-ray checking procedure.
In line with recommendations of Brazier et al. (2005) and Ubel et al. (2003) that those patients who are experiencing the health state are best place to value them, the study results would have been enhanced if valuations were gathered from patients who had actually underwent NGT placement confirmation and subsequent complications (or not). The EQ-5D questionnaire was delivered as a self-completion questionnaire in line with the intended design of the instrument (Rabin et al. 2011) . However, this also prevented the patients from clarifying any misunderstanding they may have had in completing the health state valuations. The presence of misunderstanding or unfamiliarity with the EQ-5D instrument is suspected due to several anomalous ratings (e.g. Moderate Complications Health State being rated considerably higher at 0Á877 than No Complications Health State at 0Á143 by one participant) and the extremely low overall combined utility score of Severe Complications Health State at 0Á036. In practical terms, this means that participants valued Severe Complications as being very near 0, the score representing death on the EQ-5D instrument. In addition, gaining access to actual patient data pertaining to complication rates and outcomes in terms of additional care required would have facilitated a more accurate representation than the current literature based approach. Currently, the study assumes a set profile of care for each level of complication, with a specific focus on bronchopulmonary complications as these are the most common (Sparks et al. 2011) . However, single case studies are available which report on a wider variety of complications (e.g. Pandey et al. 2004) . Although these are extremely rare their inclusion may impact on this study estimates. By accessing actual patient level data, this limitation to this study may be addressed.
A final consideration is the sample size of 23 for health state valuations. Although debate exists in the literature regarding optimal sample size calculations for cost effectiveness analyses (Briggs & Gray 1998 , Laska et al. 1999 ), a larger sample size for this current work would have potentially provided a more accurate estimate of health state valuations with smaller SEs than the current sample.
Conclusion
The aim of this study was to evaluate the effectiveness of pH paper testing of aspirate and chest x-ray as outlined in the currently recommended NPSA algorithm (NPSA 2011c) for determining NGT placement in terms of cost and patient outcome for adult patients. Using economic modelling, an ICER was calculated in terms of costs of checking and subsequent complications and QALY gains. The study adopted a third party payer perspective (NHS) in a Scottish setting. The time horizon for the study was 0Á125 years in line with the recommendations for duration of short-term NGT use and incorporating average length of stay for the population under consideration (hospitalized adult patients in Scotland). Patient outcome was measured in terms of QALYs gained. QALY values were obtained using a generic validated questionnaire and calculated for the 0Á125 year time horizon. A systematic search of the literature was conducted to source effectiveness data and probability rates for complications and consequences. Sensitivity analysis was conducted to test the final model assumptions and uncertainties around the model inputs. Although the success of aspiration attempts and chest x-ray interpretation accuracy were found to significantly alter the ICER estimates, the current recommendation of pH testing of aspirate as a first line approach for the confirmation of NGT placement remains the most cost effective method in terms of cost and patient outcome (measured through QALY gains). The results confirm current UK recommendations from the NPSA (2011c) and may have wider policy implications for those areas whereby chest x-ray is recommended as the first and only acceptable confirmation approach.
